The B7/BB1 antigen provides one of several costimulatory signals for the activation of CD4+ T lymphocytes by human blood dendritic cells in vitro. (original) (raw)
Amendment history:
- Correction(April 1993)
Research Article Free access | 10.1172/JCI115840
L Koulova, S A Soergel, E A Clark, R M Steinman, and B Dupont
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021.
Find articles by Young, J. in:[JCI](/search/results?q=author.first%5Fname%3A%22J W%22+author.last%5Fname%3A%22Young%22&search%5Ftype=advanced) |PubMed |Google Scholar
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021.
Find articles by Koulova, L. in:JCI |PubMed |Google Scholar
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021.
Find articles by Soergel, S. in:[JCI](/search/results?q=author.first%5Fname%3A%22S A%22+author.last%5Fname%3A%22Soergel%22&search%5Ftype=advanced) |PubMed |Google Scholar
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021.
Find articles by Clark, E. in:[JCI](/search/results?q=author.first%5Fname%3A%22E A%22+author.last%5Fname%3A%22Clark%22&search%5Ftype=advanced) |PubMed |Google Scholar
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021.
Find articles by Steinman, R. in:[JCI](/search/results?q=author.first%5Fname%3A%22R M%22+author.last%5Fname%3A%22Steinman%22&search%5Ftype=advanced) |PubMed |Google Scholar
Laboratory of Cellular Physiology and Immunology, Rockefeller University, New York 10021.
Find articles by Dupont, B. in:JCI |PubMed |Google Scholar
Published July 1, 1992 -More info
Published July 1, 1992 -Version history
T cells respond to peptide antigen in association with MHC products on antigen-presenting cells (APCs). A number of accessory or costimulatory molecules have been identified that also contribute to T cell activation. Several of the known accessory molecules are expressed by freshly isolated dendritic cells, a distinctive leukocyte that is the most potent APC for the initiation of primary T cell responses. These include ICAM-1 (CD54), LFA-3 (CD58), and class I and II MHC products. Dendritic cells also constitutively express the accessory ligand for CD28, B7/BB1, which has not been previously identified on circulating leukocytes freshly isolated from peripheral blood. Dendritic cell expression of both B7/BB1 and ICAM-1 (CD54) increases after binding to allogeneic T cells. Individual mAbs against several of the respective accessory T cell receptors, e.g., anti-CD2, anti-CD4, anti-CD11a, and anti-CD28, inhibit T cell proliferation in the dendritic cell-stimulated allogeneic mixed leukocyte reaction (MLR) by 40-70%. Combinations of these mAbs are synergistic in achieving near total inhibition. Other T cell-reactive mAbs, e.g., anti-CD5 and anti-CD45, are not inhibitory. Lymphokine secretion and blast transformation are similarly reduced when active accessory ligand-receptor interactions are blocked in the dendritic cell-stimulated allogeneic MLR. Dendritic cells are unusual in their comparably higher expression of accessory ligands, among which B7/BB1 can now be included. These are pertinent to the efficiency with which dendritic cells in small numbers elicit strong primary T cell proliferative and effector responses.
Click on an image below to see the page. View PDF of the complete article
- Version 1 (July 1, 1992): No description